{"nct_id":"NCT01088048","title":"Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2010-03-25","start_date_type":"ACTUAL","primary_completion_date":"2015-04-28","primary_completion_date_type":"ACTUAL","completion_date":"2015-04-28","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}